NCT06354738Recruiting
Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
Improving Endometrial Cancer Assessment by Combining the New techniqUe of GENomic Profiling With Surgical Extra uterIne disEase Assessment
Source: ClinicalTrials.gov · Last updated 17 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 21 Mar 2024
- Start date
- 16 Jan 2023
- Primary completion date
- 1 Nov 2028
- Lead sponsor
- University Hospital, Gasthuisberg
- Diseases
- Endometrial cancer
- NCT number
- NCT06354738
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 16 Jan 2023 to the primary completion date, 1 Nov 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant has a history of pelvic or para-aortic lymph node dissection or sampling, previous pelvic (and/or para-aortic) radiotherapy, previous neoadjuvant chemotherapy
- Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Study
Other illness
- Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
Who the study is looking for
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained before any screening procedures
- Women ≥ 18 years
- First diagnosis of EC, all disease stages and all histo-types
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Gasthuisberg, Katholieke Universiteit Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.